Stockscreener 앱 받기
0.3905
8.76%
-0.0375
시간 외 거래:
.39
-0.0005
-0.13%
전일 마감가:
$0.428
열려 있는:
$0.44
하루 거래량:
1.19M
Relative Volume:
0.74
시가총액:
$30.03M
수익:
$4.72B
순이익/손실:
$-123.85M
주가수익비율:
-0.0273
EPS:
-14.2981
순현금흐름:
$-303.12M
1주 성능:
-13.41%
1개월 성능:
-63.84%
6개월 성능:
-86.10%
1년 성능:
+0.00%
1일 변동 폭
$0.3849
$0.44
1주일 범위
$0.3849
$0.5015
52주 변동 폭
$0.3849
$4.6887
Accendra Health Inc Stock (ACH) Company Profile
명칭
Accendra Health Inc
전화
(804) 277-4304
주소
4435 WATERFRONT DRIVE, GLEN ALLEN
Compare ACH vs MCK, COR, CAH, HSIC, AHG
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACH
Accendra Health Inc
|
0.3905 | 30.03M | 4.72B | -123.85M | -303.12M | -14.30 |
MCK
Mckesson Corp
|
955.76 | 111.43B | 403.43B | 5.10B | 5.41B | 38.47 |
COR
Cencora Inc
|
325.06 | 62.03B | 328.68B | 2.55B | 1.56B | 13.03 |
CAH
Cardinal Health Inc
|
238.08 | 55.13B | 250.74B | 1.55B | 4.39B | 6.5398 |
HSIC
Henry Schein Inc
|
84.23 | 9.39B | 13.38B | 418.00M | 391.00M | 3.3112 |
AHG
Akso Health Group Adr
|
1.37 | 1.17B | 14.85M | -136.07M | 7.25M | -0.4726 |
Accendra Health Inc Stock (ACH) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-08-11 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2026-08-11 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-11-03 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-07-19 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-02-26 | 개시 | Leerink Partners | Market Perform |
| 2024-01-03 | 개시 | Barclays | Equal Weight |
| 2022-10-13 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2022-10-12 | 다운그레이드 | BofA Securities | Buy → Underperform |
| 2022-10-12 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2022-04-26 | 재개 | Citigroup | Buy |
| 2022-04-01 | 재개 | Credit Suisse | Neutral |
| 2022-03-30 | 재개 | JP Morgan | Underweight |
| 2022-03-23 | 업그레이드 | HSBC Securities | Reduce → Hold |
| 2021-04-08 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2021-03-08 | 업그레이드 | Goldman | Sell → Buy |
| 2020-12-17 | 업그레이드 | UBS | Neutral → Buy |
| 2020-09-25 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-07-14 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-05-05 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2020-04-23 | 재개 | Credit Suisse | Neutral |
| 2020-01-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2020-01-07 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-11-15 | 업그레이드 | CLSA | Underperform → Outperform |
| 2019-09-06 | 재확인 | BofA/Merrill | Neutral |
| 2019-04-10 | 재확인 | BofA/Merrill | Neutral |
| 2019-04-03 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-04-01 | 업그레이드 | JP Morgan | Underweight → Overweight |
| 2019-01-18 | 업그레이드 | HSBC Securities | Hold → Buy |
| 2019-01-17 | 개시 | UBS | Neutral |
| 2019-01-15 | 업그레이드 | CLSA | Underperform → Outperform |
| 2018-12-14 | 다운그레이드 | Morgan Stanley | Overweight → Underweight |
| 2018-12-12 | 다운그레이드 | Goldman | Buy → Neutral |
| 2018-09-28 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-11 | 다운그레이드 | CLSA | Outperform → Sell |
| 2018-04-10 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2018-03-26 | 업그레이드 | Goldman | Sell → Neutral |
| 2017-11-02 | 다운그레이드 | HSBC Securities | Buy → Hold |
| 2016-03-24 | 업그레이드 | Goldman | Sell → Neutral |
| 2015-12-07 | 다운그레이드 | Goldman | Neutral → Sell |
| 2015-08-31 | 업그레이드 | Credit Suisse | Underperform → Neutral |
| 2012-08-01 | 개시 | HSBC Securities | Underweight |
| 2009-08-05 | 업그레이드 | Citigroup | Sell → Buy |
| 2008-12-01 | 다운그레이드 | HSBC Securities | Neutral → Underweight |
모두보기
Accendra Health Inc 주식(ACH)의 최신 뉴스
New Strong Sell Stocks for October 9th - Zacks Investment Research
Form 4 Accendra Health Inc For: 6 October By Investing.com - Investing.com Nigeria
A 283,554-share grant to Accendra Health (ACH) CEO vests one-third annually over three years. - Stock Titan
Form 4 ACCENDRA HEALTH INC/VA/ For: Oct 05 Filed by: Gardner-Smith Kenneth - StreetInsider
New Strong Sell Stocks for October 6th - Zacks Investment Research
Lobbying Update: $200,000 of ACCENDRA HEALTH INC. lobbying was just disclosed - Quiver Quantitative
Accendra Health Inc Revenue Breakdown – DUS:6OM - tradingview.com
Accendra Health, Inc. $ACH Shares Newly Bought by Bank of America Corp DE - MarketBeat
Accendra Health (NYSE:ACH) Stock Forecast & Analyst Predictions - Simply Wall Street
Accendra Health (ACH) CFO surrenders shares for taxes tied to stock vesting; he holds 286,268 shares afterward. - Stock Titan
Accendra Health names new CEO, chief commercial officer - Richmond Times-Dispatch
Accendra Health appoints new CEO and commercial chief - The Globe and Mail
Accendra Health Names Kenneth Gardner-Smith CEO, Adds Chief Commercial Officer - citybiz
Accendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of Growth - Business Wire
Accendra Health Inc. (ACH) Slips 3.15% to $1.07 as Shares Drift Toward Lower SupportStraddle Setup - careplusvn.com
Accendra Health (ACH) Holds Steady at $1.21 as Shares Trade Within Defined Support and Resistance Range - siam.in
Connor Clark & Lunn Investment Management Ltd. Invests $4.41 Million in Accendra Health, Inc. $ACH - MarketBeat
2,536,699 Shares in Accendra Health, Inc. $ACH Purchased by Paradigm Capital Management Inc. NY - MarketBeat
Accendra (ACH) Latest Quarter: EPS Does Not Reach the Reported Estimate in the Reported Period; Closing Reaction: The Share Price Sheds 4.67% at the CloseEarnings Surprise Report - vinanet.vn
Accendra (ACH) Quarterly Figures: EPS Does Not Reach the Reported Estimate under the Current Snapshot; Stock Move: The Stock Gains 5.61% for the Current SessionBasic EPS Analysis - vinanet.vn
Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com South Africa
Accendra Health Inc (ACH) (Q2 2026) Earnings Call Highlights: Na - GuruFocus
Accendra Health provides update on CEO transition, credit facility - HME News
Accendra Health Drops Equity Issuance Plan, Targets September CEO Announcement - citybiz
Accendra Health drops equity issuance plan as CEO succession process advances - Yahoo Finance
Accendra Health scraps equity program, expects CEO successor - Investing.com
Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com Nigeria
Accendra Health sells first of two non-core assets, expects about $45 million cash injection - Bitget
Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com India
Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com Canada
Form 8K Accendra Health Inc For: 17 August By Investing.com - Investing.com UK
Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com Canada
Accendra Health to forgo ATM program, sees ~$45M from two asset sales; CEO successor expected by mid-September - TradingView
Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com India
Accendra Health scraps equity program, expects CEO successor By Investing.com - Investing.com UK
Accendra Health Updates on Capital Allocation and CEO Succession Timing Plans - Yahoo Finance
Accendra Health ready to put weak Q2 in rear view - HME News
Accendra Health (ACH) Drops 9% to $1.10 as Selling Pressure PersistsAnchored VWAP - vinanet.vn
Accendra Health (NYSE:ACH) Rating Lowered to "Hold" at Robert W. Baird - MarketBeat
Dimensional Fund Advisors LP Buys Shares of 2,606,620 Accendra Health, Inc. $ACH - MarketBeat
Accendra Health, Inc. (ACH) stock price, news, quote and history - Yahoo Finance UK
Baird downgrades Accendra Health stock rating on weak results By Investing.com - Investing.com South Africa
Accendra Health, Inc. (ACH) Stock Price, News, Quote & History - Yahoo! Finance Canada
Baird downgrades Accendra Health stock rating on weak results By Investing.com - Investing.com UK
Accendra Health adopts tax asset preservation plan - HME News
Accendra Health's Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search - marketscreener.com
Citigroup Downgrades Accendra Health to Neutral From Buy, Adjusts PT to $1.50 From $4.50 - marketscreener.com
Baird Downgrades Accendra Health to Neutral From Outperform, Adjusts PT to $1.50 From $6 - marketscreener.com
ACCENDRA HEALTH INC : BAIRD CUTS TO NEUTRAL RATING; CUTS TARGET PRICE TO $1.5 FROM $6 - Bitget
Baird downgrades Accendra Health stock rating on weak results - Investing.com
Accendra Health Inc (ACH) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.27%
4.08%
자본화:
|
볼륨(24시간):